[心力衰竭与左心室喷射分数减少 (HFrEF,HFmrEF) ]
Thomas Seiler1, Matthias Paul2
1Herzzentrum Luzern, Luzerner Kantonsspital, Luzern, Switzerland.
Therapeutische Umschau. Revue therapeutique
|May 23, 2024
概括
心力衰竭影响全球数百万人,并且正在上升. 这篇文章详细介绍了心力衰竭的诊断和治疗选择,其中包括减少喷射率 (HFrEF) 和轻微减少喷射率 (HFmrEF).
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
背景情况:
- 心力衰竭是一种全球性流行病,影响了超过6400万人,代表了心血管疾病的晚期阶段.
- 它的流行率正在增加,需要有效的预防,早期检测和管理策略.
- 目前的治疗方法根据左心室喷射率 (LVEF) 的减少而有所不同.
研究的目的:
- 为了讨论心力衰竭的诊断.
- 解释心力衰竭的各种治疗选择,减少LVEF (HFrEF) 和心力衰竭轻度减少LVEF (HFmrEF).
主要方法:
- 本文提供了当前心力衰竭诊断方法的全面概述.
- 它审查了针对不同类别的LVEF量身定制的既定和新兴的治疗策略.
主要成果:
- 最佳的心力衰竭管理可以减少住院,降低死亡率,提高患者的生活质量.
- 了解LVEF对于选择适当的治疗途径至关重要.
结论:
- 早期诊断和量身定制的治疗对于管理日益增长的心力衰竭负担至关重要.
- 本综述旨在指导临床医生优化对HFrEF和HFmrEF患者的护理.
相关概念视频
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Heart Failure Drugs: β-Blockers
336
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
421
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
421
Heart Failure Drugs: Diuretics
363
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
363
Anatomy of the Heart
108.6K
The human heart is made up of three layers of tissue that are surrounded by the pericardium, a membrane that protects and confines the heart. The outermost layer, closest to the pericardium, is the epicardium. The pericardial cavity separates the pericardium from the epicardium. Beneath the epicardium is the myocardium, the middle layer, and the endocardium, the innermost layer. There are four chambers of the heart: the right atrium, the right ventricle, the left atrium, and the left ventricle.
108.6K


